EGFR and non-small cell lung carcinoma: The results presented here demonstrate the performance of Roche cfDNA tubes, including a comparison with standard K2EDTA tubes, for the detection of defined EGFR mutations in plasma derived from patients with NSCLC or from healthy donors using the cobas EGFR test.